Jeff Yass’s BioAmber Inc. BIOA Stock Holding History

Jeff Yass’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,700	Closed	-$33K	–	10155
2017 Q2	$33K	Buy	+12,700	New	+$29.2K	﹤0.01%	8964

Other funds holding BIOA

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jeff Yass's BIOA Position: Q3 2017 in Review

Jeff Yass sold out of BioAmber Inc. (BIOA) in Q3 2017, closing a stake of 10,991 shares — an estimated $28K sold.

Jeff Yass first reported a position in BIOA in Q4 2014 and held it in 2 quarters. The position peaked at $90K in Q4 2014. 30 funds tracked by Wall St. Rank hold BIOA as of Q3 2017.

Jeff Yass reported no remaining BioAmber Inc. position as of Q3 2017 after selling out during the quarter.
Jeff Yass sold 10,991 BioAmber Inc. shares in Q3 2017, an estimated $28K.
Jeff Yass first reported a position in BioAmber Inc. in Q4 2014 and held it in 2 quarters.
Jeff Yass's BioAmber Inc. position peaked at $90K in Q4 2014.
30 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2017.

Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.